Reckitt Benckiser Group plc (LON:RKT – Get Free Report) insider Kris Licht sold 3,799 shares of the firm’s stock in a transaction on Friday, March 21st. The stock was sold at an average price of GBX 5,177 ($66.89), for a total value of £196,674.23 ($254,133.91).
Reckitt Benckiser Group Stock Performance
LON:RKT opened at GBX 5,130 ($66.29) on Tuesday. Reckitt Benckiser Group plc has a twelve month low of GBX 4,034 ($52.13) and a twelve month high of GBX 5,418 ($70.01). The company has a quick ratio of 0.46, a current ratio of 0.69 and a debt-to-equity ratio of 110.26. The firm has a market capitalization of £35.00 billion, a P/E ratio of 23.48, a P/E/G ratio of 1.10 and a beta of 0.09. The company has a fifty day moving average of GBX 5,198.14 and a 200-day moving average of GBX 4,907.93.
Reckitt Benckiser Group (LON:RKT – Get Free Report) last posted its earnings results on Thursday, March 6th. The company reported GBX 349.70 ($4.52) earnings per share for the quarter. Reckitt Benckiser Group had a net margin of 10.78% and a return on equity of 18.70%. As a group, sell-side analysts anticipate that Reckitt Benckiser Group plc will post 331.2110727 EPS for the current year.
Reckitt Benckiser Group Increases Dividend
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- Investing In Automotive Stocks
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- Expert Stock Trading Psychology Tips
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.